| Id: | acc4450 |
| Group: | 1sens |
| Protein: | IkappaBalpha |
| Gene Symbol: | Nfkbia |
| Protein Id: | Q9Z1E3 |
| Protein Name: | IKBA_MOUSE |
| PTM: | phosphorylation |
| Site: | Ser32 |
| Site Sequence: | ERLVDDRHDSGLDSMKDEEYE |
| Disease Category: | Endocrine and metabolic diseases |
| Disease: | Fatty Liver Disease |
| Disease Subtype: | Non-Alcoholic Fatty Liver Disease |
| Disease Cellline: | |
| Disease Info: | |
| Drug: | Alpinetin? |
| Drug Info: | "Alpinetin is a flavonoid compound with various pharmacological activities, such as anti - inflammatory and antioxidant properties." |
| Effect: | modulate |
| Effect Info: | "ALP inhibits the phosphorylation of IκBα, prevents its degradation, maintains NF-κB in an inactive state in the cytoplasm, and thus alleviates NAFLD-related inflammation." |
| Note: | |
| Score: | 4.0 |
| Pubmed(PMID): | 29156529 |
| Sentence Index: | 29156529_14 |
| Sentence: | "Further, abnormal lipid metabolism caused by HF was alleviated by ALP, which was associated with the decreased Stearoyl-CoA desaturase 1 (SCD1), fatty acid synthase (FAS), sterol element regulatory binding protein 1c (SREBP-1c), Liver X Receptor (LXR)-alpha, elongases of very long-chain fatty acids (Elovl)-2, p-insulin receptor substrate 1 (IRS1) expressions, and increased PPARalpha levels." |
Sequence & Structure:
MFQPAGHGQDWAMEGPRDGLKKERLVDDRHDSGLDSMKDEEYEQMVKELREIRLQPQEAPLAAEPWKQQLTEDGDSFLHLAIIHEEKPLTMEVIGQVKGDLAFLNFQNNLQQTPLHLAVITNQPGIAEALLKAGCDPELRDFRGNTPLHLACEQGCLASVAVLTQTCTPQHLHSVLQATNYNGHTCLHLASIHGYLAIVEHLVTLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESEDEESYDTESEFTEDELPYDDCVFGGQRLTL
No data.
No data.
Protein Tractability:
source: Open TargetsNo data.
PTM Intensity:
source: CPTACNo data.
PTM-Disease Association:
source: PTMDNo data.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.
